Structure function studies of Vectofusin lentiviral transduction enhancers in human hematopoietic stem/progenitor cells

被引：0
|
作者：
Majdoul, S. [1 ,2 ,3 ]
Biton, S. [1 ,2 ]
Seye, A. K. [1 ,2 ]
Holic, N. [1 ,2 ,3 ]
Vermeer, L. [4 ,5 ]
Kichler, A. [5 ,6 ]
Bechinger, B. [4 ,5 ]
Galy, A. [1 ,2 ,3 ]
Fenard, D. [1 ,2 ,3 ]
机构：
[1] Genethon, F-91002 Evry, France
[2] Genethon, INSERM, UMR S951, F-91002 Evry, France
[3] Univ Evry Val Essonne, UMR S951, F-91002 Evry, France
[4] CNRS, Inst Chim, UMR 7177, F-67401 Strasbourg, France
[5] Univ Strasbourg, F-67000 Strasbourg, France
[6] CNRS, UMR 7199, F-67401 Illkirch Graffenstaden, France
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P029
引用
收藏
页码：A65 / A65
页数：1
相关论文
共 50 条
  • [21] The Immunosuppressant Drug Rapamycin Relieves Lentiviral Transduction Resistance in Human Hematopoietic Stem Cells
    Wang, Cathy X.
    Torbett, Bruce E.
    MOLECULAR THERAPY, 2012, 20 : S198 - S198
  • [22] Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells
    Wang, Cathy X.
    Sather, Blythe D.
    Wang, Xuefeng
    Adair, Jennifer
    Khan, Iram
    Singh, Swati
    Lang, Shanshan
    Adams, Amie
    Curinga, Gabrielle
    Kiem, Hans-Peter
    Miao, Carol H.
    Rawlings, David J.
    Torbett, Bruce E.
    BLOOD, 2014, 124 (06) : 913 - 923
  • [23] Hematopoieitic safety evaluation of Vectofusin-1, a new culture additive enhancing lentiviral vector entry into human hematopoietic progenitor cells
    Buisset, J.
    Seye, A. K.
    Ingrao, D.
    Galy, A.
    Fenard, D.
    HUMAN GENE THERAPY, 2012, 23 (10) : A111 - A111
  • [24] dmPGE2 and poloxamer-F108 enhance transduction of human hematopoietic stem and progenitor cells with a β-globin lentiviral vector
    Masiuk, K. E.
    Hollis, R. P.
    Kohn, D. B.
    Campo-Fernandez, B.
    HUMAN GENE THERAPY, 2018, 29 (12) : A36 - A36
  • [25] Effective Retroviral Transduction of Primary T Cells and Hematopoietic Stem Cells Using the Soluble Transduction Enhancer: Vectofusin-1
    Radek, Constanze
    Bernadin, Ornellie
    Straesser, Pia
    Drechsel, Katharina
    Kaiser, Andrew D. M.
    Verhoeyen, Els
    Johnston, Ian C. D.
    MOLECULAR THERAPY, 2017, 25 (05) : 220 - 221
  • [26] Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy
    Baldwin, Kismet
    Urbinati, Fabrizia
    Romero, Zulema
    Campo-Fernandez, Beatriz
    Kaufman, Michael L.
    Cooper, Aaron R.
    Masiuk, Katelyn
    Hollis, Roger P.
    Kohn, Donald B.
    STEM CELLS, 2015, 33 (05) : 1532 - 1542
  • [27] Transduction of Human Hematopoietic Stem Cells by RD114-TR-Pseudotyped Lentiviral Vectors
    Stornaiuolo, Anna A.
    Di Nunzio, Francesca F.
    Piovani, Bianca B.
    Cosset, Francois F. -L.
    Mavilio, Fulvio F.
    MOLECULAR THERAPY, 2006, 13 : S320 - S320
  • [28] Optimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy
    Jang, Yoonjeong
    Kim, Yoon-Sang
    Wielgosz, Matthew M.
    Ferrara, Francesca
    Ma, Zhijun
    Condori, Jose
    Palmer, Lance E.
    Zhao, Xiwen
    Kang, Guolian
    Rawlings, David J.
    Zhou, Sheng
    Ryu, Byoung Y.
    GENE THERAPY, 2020, 27 (12) : 545 - 556
  • [29] Optimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy
    Yoonjeong Jang
    Yoon-Sang Kim
    Matthew M. Wielgosz
    Francesca Ferrara
    Zhijun Ma
    Jose Condori
    Lance E. Palmer
    Xiwen Zhao
    Guolian Kang
    David J. Rawlings
    Sheng Zhou
    Byoung Y. Ryu
    Gene Therapy, 2020, 27 : 545 - 556
  • [30] Efficient Induction of Hematopoietic Progenitor/Stem Cell Differentiation by Lentiviral Gene Transduction of TAL1/SCL Into Human ES Cells.
    Kurita, Ryo
    Miura, Yoshie
    Okada, Michiyo
    Kageyama, Rui
    Hiramoto, Takafumi
    Yokoo, Tomoko
    Narusawa, Megumi
    Suehiro, Youko
    Inoue, Hiroyuki
    Marumoto, Tomotoshi
    Takahashi, Atsushi
    Tani, Kenzaburo
    BLOOD, 2009, 114 (22) : 595 - 595
12345